Lomotil and Flolan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lomotil (atropine sulfate; diphenoxylate hydrochloride) and Flolan (epoprostenol sodium). Common drug interactions include hypoxia among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Lomotil and Flolan. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Lomotil?

Lomotil has active ingredients of atropine sulfate; diphenoxylate hydrochloride. It is often used in diarrhea. eHealthMe is studying from 19,184 Lomotil users. Check the latest studies of Lomotil.

What is Flolan?

Flolan has active ingredients of epoprostenol sodium. eHealthMe is studying from 10,067 Flolan users. Check the latest studies of Flolan.



On Jul, 31, 2026

22 people who take Lomotil and Flolan together, and have interactions are studied.

Lomotil and Flolan drug interactions.

What are the common drug interactions of Lomotil and Flolan, by gender? *:

female:

  1. Hypoxia (low oxygen in tissues)
  2. Pulmonary haemorrhage (acute bleeding from the lung)
  3. Cardiac failure
  4. Catheter related complication
  5. Circulatory collapse
  6. Death
  7. Dyspnoea (difficult or laboured respiration)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Heparin-induced thrombocytopenia
  10. Bradycardia (abnormally slow heart action)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Arthralgia (joint pain)
  3. Viral infection
  4. Blood culture positive
  5. Central line infection (infection by central line in icu)
  6. Fatigue (feeling of tiredness)
  7. Haemorrhage (bleeding)
  8. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  9. Hepatic failure (liver failure)
  10. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)

What are the common drug interactions of Lomotil and Flolan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Death
  2. Impaired gastric emptying
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting
  5. Catheter site pruritus (itching at the site)
  6. Catheter site related reaction
  7. Hospitalisation
  8. Infusion site pruritus (severe itching at infusion site)
  9. Infusion site vesicles (fluid- or air-filled cavity or sac at infusion site)
  10. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hypoxia (low oxygen in tissues)
  3. Pulmonary haemorrhage (acute bleeding from the lung)
  4. Cardiac failure
  5. Circulatory collapse
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Heparin-induced thrombocytopenia
  8. Bradycardia (abnormally slow heart action)
  9. Cardiac failure high output
  10. Arthralgia (joint pain)

50-59:

  1. Haemorrhage (bleeding)
  2. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  3. Hepatic failure (liver failure)

60+:

  1. Catheter related complication
  2. Death
  3. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  4. Pulmonary hypertension secondary (increase in blood pressure in the lung artery)
  5. Oedema (fluid collection in tissue)
  6. Anaemia (lack of blood)
  7. Blood culture positive
  8. Central line infection (infection by central line in icu)
  9. Device occlusion
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 45.45%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 8 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Lomotil and Flolan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lomotil and Flolan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lomotil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flolan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lomotil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flolan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atropine sulfate; diphenoxylate hydrochloride and epoprostenol sodium (the active ingredients of Lomotil and Flolan, respectively), and Lomotil and Flolan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: